All Stories

  1. Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression
  2. Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
  3. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk
  4. Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation
  5. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation
  6. Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions
  7. Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes
  8. Alkaline phosphatase and prognosis in patients with diabetes mellitus and ischemic heart disease
  9. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy
  10. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
  11. Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut
  12. Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention
  13. Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis
  14. Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes—a subgroup analysis of the ISAR-REACT 5 trial
  15. Target and non-target vessel related events at 10 years post percutaneous coronary intervention
  16. Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes
  17. Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis
  18. Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging
  19. Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes
  20. A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results:...
  21. Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
  22. 1-Year Results After Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves
  23. Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data
  24. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention
  25. Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry
  26. Prognostic value of haemoglobin drop in patients with acute coronary syndromes
  27. Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves
  28. Long‐term clinical outcomes after drug eluting stent implantation with and without stent overlap
  29. Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial
  30. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate
  31. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes
  32. Pushing the limits for interventional treatment of aortic valve stenosis
  33. Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial
  34. Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis
  35. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention
  36. Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
  37. Association between duration of drug-coated balloon inflation and efficacy in patients with drug-eluting stent restenosis
  38. First-in-Man Simultaneous Aortic and Mitral Valve Transcatheter Implantation Using Patient-Customized Prostheses
  39. Reply
  40. Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis
  41. Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation
  42. Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation
  43. Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials
  44. Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
  45. Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
  46. Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
  47. Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves
  48. Aspartate aminotransferase and mortality in patients with ischemic heart disease
  49. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells
  50. 10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents
  51. Early Outcome in Patients Requiring Conversion to General Anesthesia During Transfemoral Transcatheter Aortic Valve Implantation
  52. Successful Repeat Transcatheter Mitral Valve Replacement After Late Prosthesis Failure
  53. Simultaneous ballooning and transcatheter valve implantation as a back-up maneuver in bicuspid aortic valve with horizontal aorta
  54. Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials
  55. 1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve
  56. Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – A propensity score-matched analysis
  57. Hypocholesterolaemia and mortality in patients with coronary artery disease
  58. Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease
  59. Efficacy of drug‐coated balloon angioplasty in early versus late occurring drug‐eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials
  60. Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment
  61. Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction
  62. TCT-283 10-Year Clinical Outcomes From a Trial of 3 Limus-Eluting Stents With Different Polymer Coatings in Diabetic Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial
  63. TCT-711 Prevalence and Clinical Impact of Bioprosthesis Thrombosis After Transcatheter Aortic Valve Implantation. A Collaborative Meta-Analysis
  64. TCT-97 Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions Mid-Term Angiographic and Optical Coherence Tomography Findings from the ISAR-OCT-CTO Registry
  65. Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease
  66. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
  67. Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions
  68. Simultaneous Transseptal Mitral Valve-in-Valve and Trans-Bypass Aortic Valve Treatment Using Balloon-Expandable Valves
  69. Procedural and clinical performance of dual‐ versus single‐catheter strategy for transradial coronary angiography: A meta‐analysis of randomized trials
  70. Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials
  71. Two birds with one stone: transcatheter valve-in-valve treatment of a failed surgical bioprosthesis with concomitant severe stenosis and paravalvular leak
  72. Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – a propensity score-matched analysis
  73. Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent
  74. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis
  75. Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction
  76. U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction
  77. Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction
  78. International LAMPOON: first European experience with laceration of the anterior mitral valve leaflet prior to transseptal transcatheter mitral valve implantation
  79. High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction
  80. P2273Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis
  81. P4559Outcome after single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation
  82. Neoatherosclerosis in Patients With Coronary Stent Thrombosis
  83. Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials
  84. Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study
  85. Reduction of thrombus burden
  86. Sex differences in the outcome after percutaneous coronary intervention – A propensity matching analysis
  87. Neoatherosclerosis: from basic principles to intravascular imaging
  88. Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials
  89. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease
  90. 37 Optical coherence tomography tissue coverage and characterization by grey-scale signal intensity analysis post bifurcation stenting with new generation bioabsorbable polymer everolimus-eluting stents
  91. Consequences of Vascular Calcification
  92. Prognostic value of alkaline phosphatase in patients with acute coronary syndromes
  93. Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials
  94. TCT-419 Long-term clinical outcomes of patients presenting with in-stent restenosis after drug-eluting stent implantation for unprotected left main coronary artery. A pooled analysis of the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 randomized trials
  95. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis
  96. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents
  97. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
  98. Alkaline phosphatase and prognosis in patients with coronary artery disease
  99. Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease
  100. TCT-399 Impact of post-dilatation on angiographic and clinical outcomes of patients undergoing bioresorbable scaffold implantation in clinical practice
  101. TCT-414 Two-year outcomes of patients with acute coronary syndrome versus stable coronary disease undergoing bioresorbable scaffold implantation
  102. TCT-58 Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable scaffolds during daily practice – 2-year results from the ISAR-ABSORB Registry
  103. Optical coherence tomography in drug‑eluting stent restenosis: a technique in need of a strategy
  104. Biodegradable-polymer drug-eluting stents: back to the future?
  105. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis
  106. Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials
  107. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials
  108. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium
  109. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
  110. TCT-373 Temporal course of neointimal maturity after implantation of biodegradable polymer sirolimus-eluting stents as assessed by optical coherence tomography gray-scale signal intensity at 3, 6 and 9 months
  111. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site – CLOSURE device versus manual...
  112. Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort
  113. TCT-591 Stent coverage and neointimal maturity in a randomized trial of limus-eluting stents with biodegradable polymer versus permanent polymer coatings assessed by optical coherence tomography